UNIVERSITY OF WASHINGTON

- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2008-02-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 25
- Registration Number
- NCT00609557
Computer Assisted Relaxation Learning for Dental Offices
- Conditions
- Dental Anxiety
- Interventions
- Behavioral: Computer Assisted Relaxation LearningBehavioral: Pamphlet
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 84
- Registration Number
- NCT00609648
- Locations
- ๐บ๐ธ
Dr. Gary Templeman, DDS, Corvallis, Oregon, United States
๐บ๐ธMichael C Hazel, DMD, PC, West Linn, Oregon, United States
๐บ๐ธNorthwest Dental Fears Research, Bremerton, Washington, United States
Disseminating Organizational SBI Services at Trauma Centers
- Conditions
- Alcohol DependenceAlcohol Abuse
- Interventions
- Behavioral: Brief Intervention
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 878
- Registration Number
- NCT00607620
- Locations
- ๐บ๐ธ
University of Washington, Seattle, Washington, United States
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Promyelocytic Leukemia (M3)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Recurrent Adult Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 50
- Registration Number
- NCT00602225
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
- Conditions
- Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisRecurrent Adult Hodgkin LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma
- Interventions
- Biological: rituximabOther: pharmacological studyOther: laboratory biomarker analysisGenetic: gene expression analysis
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 29
- Registration Number
- NCT00601718
- Locations
- ๐บ๐ธ
Puget Sound Oncology Consortium, Seattle, Washington, United States
ACY-7 Oral Administration of Acyline
- Conditions
- Healthy
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 4
- Registration Number
- NCT00603187
- Locations
- ๐บ๐ธ
University of Washington, Seattle, Washington, United States
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
- Conditions
- Spinal Cord InjuriesMajor Depressive DisorderDysthymia
- Interventions
- Drug: placebo
- First Posted Date
- 2008-01-14
- Last Posted Date
- 2015-01-01
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 133
- Registration Number
- NCT00592384
- Locations
- ๐บ๐ธ
University of Alabama, Birmingham, Alabama, United States
๐บ๐ธUniversity of Miami, Miami, Florida, United States
๐บ๐ธRehabilitation Institute of Chicago, Chicago, Illinois, United States
Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder
- Conditions
- Bipolar Disorder
- Interventions
- Behavioral: Treatment As Usual (TAU)Behavioral: Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 36
- Registration Number
- NCT00576355
- Locations
- ๐บ๐ธ
Seattle Children's Hospital, Seattle, Washington, United States
Stimulant Abuser Groups to Engage in 12-Step
- Conditions
- Drug Abuse
- Interventions
- Behavioral: STAGE-12Behavioral: Treatment as Usual
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 471
- Registration Number
- NCT00573183
- Locations
- ๐บ๐ธ
Gateway Community Services, Jacksonville, Florida, United States
๐บ๐ธHina Mauka Kaneohe Rehabilitation Services, Kaneohe, Hawaii, United States
๐บ๐ธMaryhaven, Inc., Columbus, Ohio, United States
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
- Conditions
- Death, Sudden, CardiacCerebrovascular AccidentMyocardial Infarction
- First Posted Date
- 2007-12-13
- Last Posted Date
- 2016-11-09
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00573092
- Locations
- ๐บ๐ธ
Cardiovascular Health Research Unit, Seattle, Washington, United States